Product
Spiriva Handihaler
Aliases
Spiriva Handihaler (Tiotropium Bromide) 18 mcg
Name
Spiriva
INN Name
tiotropium bromide monohydrate
FDA Approved
Yes
1 clinical trial
3 organizations
1 indication
1 document
Indication
Chronic Obstructive Pulmonary DiseaseClinical trial
A Multicenter, Randomized, Placebo-Controlled, Crossover, Single Dose Study To Demonstrate Clinical Pharmacodynamic Bioequivalence of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)Status: Completed, Estimated PCD: 2023-08-11
Document
DailyMed Label: Spiriva Organization
Boehringer Ingelheim Pharmaceuticals, Inc.Organization
A-S Medication SolutionsOrganization
Physicians Total Care, Inc.